Skip to main content
EFSA Journal logoLink to EFSA Journal
. 2011 Dec 5;9(12):2469. doi: 10.2903/j.efsa.2011.2469

Scientific Opinion on the substantiation of a health claim related to diacylglycerol (DAG) oil and reduction of body weight pursuant to Article 13(5) of Regulation (EC) No 1924/2006

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
PMCID: PMC13093202  PMID: 42016001

Abstract

Following an application from Kao Corporation, submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of the United Kingdom, the Panel on Dietetic Products, Nutrition and Allergies was asked to deliver an opinion on the scientific substantiation of a health claim related to diacylglycerol oil and reduction of body weight. The food constituent, diacylglycerol (DAG) oil, and the food constituents, vegetable oils of similar fatty acid composition containing mostly (>90%) triacylglycerol (TAG), which DAG oil should replace in order to obtain the claimed effect, are sufficiently characterised in relation to the claimed effect. Weight loss is a beneficial physiological effect for overweight subjects. Seven randomised controlled trials (RCTs) were identified by the applicant as being pertinent to the claim. One RCT which had major methodological limitations did not allow conclusions to be drawn for the scientific substantiation of the claim. The results from six RCTs with respect to the effect of DAG oil (as a replacement of TAG oils) on body weight are inconsistent and apparently unrelated to the DAG dose, study size or study duration, and the evidence provided in support of mechanisms by which DAG oil could exert the claimed effect in humans under the proposed conditions of use is not convincing. One unpublished meta‐analysis on the effects of DAG oil (as compared to TAG oils) on body weight in humans which included data from all these RCTs was also provided. The meta‐analysis had a number of potential sources of bias and did not provide additional information for the scientific substantiation of the claim. The Panel concludes that a cause and effect relationship has not been established between the consumption of DAG oil (as a replacement of TAG oils) and a reduction in body weight.

Keywords: Diacylglycerol, triacylglycerol, body weight, fat oxidation, energy intake, health claims

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) ; Scientific Opinion on the substantiation of a health claim related to diacylglycerol (DAG) oil and reduction of body weight pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal 2011;9(12):2469. [17 pp.]. doi: 10.2903/j.efsa.2011.2469.

Panel members: Carlo Agostoni, Jean‐Louis Bresson, Susan Fairweather‐Tait, Albert Flynn, Ines Golly, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Monika Neuhäuser‐Berthold, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Daniel Tomé, Hendrik van Loveren and Hans Verhagen

Correspondence: nda@efsa.europa.eu

Acknowledgement: The Panel wishes to thank the members of the Working Group on Claims: Carlo Agostoni, Jean‐Louis Bresson, Susan Fairweather‐Tait, Albert Flynn, Ines Golly, Marina Heinonen, Hannu Korhonen, Martinus Løvik, Ambroise Martin, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Inge Tetens, Hendrik van Loveren and Hans Verhagen for the preparatory work on this scientific opinion and Mette Kristensen for the support provided to this scientific opinion.

Adoption date: 25 November 2011

Published date: 5 December 2011

Question number: EFSA‐Q‐2011‐00751

On request from: Competent Authority of the United Kingdom following an application by Kao Corporation

References

  1. Hara K, Onizawa K, Honda H, Otsuji K, Ide T and Murata M, 1993. Dietary diacylglycerol‐dependent reduction in serum triacylglycerol concentration in rats. Annals of Nutrition and Metabolism, 37, 185–191. [DOI] [PubMed] [Google Scholar]
  2. Harris RS and Sherman H, 1954. Comparison of the nutritive values of mono‐, di‐, and triglycerides by a modified pair feeding technique. Journal of Food Science, 19, 257–262. [Google Scholar]
  3. Hibi M, Takase H, Yasunaga K, Shiiba D, Kudo N, Katsuragi Y, Meguro S and Tokimitsu I, 2007. Effect of repeated consumption of diacylglycerol oil on total and dietary fat oxidation in healthy subjects. Yakuri To Chiryo [Japanese Pharmacology and Therapeutics], 35, 1241–1248. [Google Scholar]
  4. Hibi M, Takase H, Yasunaga K, Yamaguchi T, Shiiba D, Saito S, Yokoyama R, Kudo N, Katsuragi Y, Meguro S, Shimizu A and Tokimitsu I, 2008a. Greater fat oxidation with diacylglycerol oil consumption for 14 days compared with triacylglycerol oil consumption in overweight men and women. International Journal of Obesity, 32, 1841–1847. [DOI] [PubMed] [Google Scholar]
  5. Hibi M, Takase H, Yasunaga K, Yamaguchi T, Harada U, Katsuragi Y and Tokimitsu I, 2008b. Fat utilization in healthy subjects consuming diacylglycerol oil diet: dietary and whole body fat oxidation. Lipids, 43, 517–524. [DOI] [PubMed] [Google Scholar]
  6. Hibi M, Sugiura Y, Yokoyama R, Takase H, Shiiba D, Meguro S, Katashima M, Shimizu A and Tokimitsu I, 2011. The short‐term effect of diacylglycerol oil consumption on total and dietary fat utilization in overweight women. Obesity (Silver Spring), 19, 536–540. [DOI] [PubMed] [Google Scholar]
  7. Kamphuis MM, Mela DJ and Westerterp‐Plantenga MS, 2003. Diacylglycerols affect substrate oxidation and appetite in humans. American Journal of Clinical Nutrition, 77, 1133–1139. [DOI] [PubMed] [Google Scholar]
  8. Kawashima H, Takase H, Yasunaga K, Wakaki Y, Katsuragi Y, Mori K, Yamaguchi T, Hase T, Matsuo N, Yasukawa T, Tokimitsu I and Koyama W, 2008. One‐year ad libitum consumption of diacylglycerol oil as part of a regular diet results in modest weight loss in comparison with consumption of a triacylglycerol control oil in overweight Japanese subjects. Journal of the American Dietetic Association, 108, 57–66. [DOI] [PubMed] [Google Scholar]
  9. Kimura S, Tsuchiya H, Inage H, Meguro S, Matsuo N and Tokimitsu I, 2006. Effects of dietary diacylglycerol on the energy metabolism. International Journal for Vitamin and Nutrition Research, 76, 75–79. [DOI] [PubMed] [Google Scholar]
  10. Li D, Xu T, Takase H, Tokimitsu I, Zhang P, Wang Q, Yu X and Zhang A, 2008. Diacylglycerolinduced improvement of whole‐body insulin sensitivity in type 2 diabetes mellitus: a long‐term randomized, double‐blind controlled study. Clinical Nutrition, 27, 203–211. [DOI] [PubMed] [Google Scholar]
  11. Maki KC, Davidson MH, Tsushima R, Matsuo N, Tokimitsu I, Umporowicz DM, Dicklin MR, Foster GS, Ingram KA, Anderson BD, Frost SD and Bell M, 2002. Consumption of diacylglycerol oil as part of a reduced‐energy diet enhances loss of body weight and fat in comparison with consumption of a triacylglycerol control oil. American Journal of Clinical Nutrition, 76, 1230–1236. [DOI] [PubMed] [Google Scholar]
  12. Mattson F, Baur F and Beck L, 1951. The comparative nutritive value of mono‐, di‐, and triglycerides. Journal of the American Oil Chemists' Society, 28, 386–390. [Google Scholar]
  13. Meng X, Zou D, Shi Z, Duan Z and Mao Z, 2004. Dietary diacylglycerol prevents high‐fat diet‐induced lipid accumulation in rat liver and abdominal adipose tissue. Lipids, 39, 37–41. [DOI] [PubMed] [Google Scholar]
  14. Mori Y, Nakagiri H, Kondo H, Murase T, Tokimitsu I and Tajima N, 2005. Dietary diacylglycerol reduces postprandial hyperlipidemia and ameliorates glucose intolerance in Otsuka Long‐Evans Tokushima Fatty (OLETF) rats. Nutrition, 21, 933–939. [DOI] [PubMed] [Google Scholar]
  15. Murase T, Mizuno T, Omachi T, Onizawa K, Komine Y, Kondo H, Hase T and Tokimitsu I, 2001. Dietary diacylglycerol suppresses high fat and high sucrose diet‐induced body fat accumulation in C57BL/6J mice. Journal of Lipid Research, 42, 372–378. [PubMed] [Google Scholar]
  16. Murase T, Aoki M, Wakisaka T, Hase T and Tokimitsu I, 2002. Anti‐obesity effect of dietary diacylglycerol in C57BL/6J mice: dietary diacylglycerol stimulates intestinal lipid metabolism. Journal of Lipid Research, 43, 1312–1319. [PubMed] [Google Scholar]
  17. Murata M, Ide T and Hara K, 1997. Reciprocal responses to dietary diacylglycerol of hepatic enzymes of fatty acid synthesis and oxidation in the rat. British Journal of Nutrition, 77, 107–121. [DOI] [PubMed] [Google Scholar]
  18. Nagao T, Watanabe H, Goto N, Onizawa K, Taguchi H, Matsuo N, Yasukawa T, Tsushima R, Shimasaki H and Itakura H, 2000. Dietary diacylglycerol suppresses accumulation of body fat compared to triacylglycerol in men in a double‐blind controlled trial. Journal of Nutrition, 130, 792–797. [DOI] [PubMed] [Google Scholar]
  19. Saito S, Tomonobu K, Hase T and Tokimitsu I, 2006. Effects of diacylglycerol on postprandial energy expenditure and respiratory quotient in healthy subjects. Nutrition, 22, 30–35. [DOI] [PubMed] [Google Scholar]
  20. Saito S, Hernandez‐Ono A and Ginsberg HN, 2007. Dietary 1,3‐diacylglycerol protects against diet‐induced obesity and insulin resistance. Metabolism: Clinical and Experimental, 56, 1566–1575. [DOI] [PubMed] [Google Scholar]
  21. Saito S, Shoji K, Yokoyama R, Hibi M, Takase H, Meguro S, Kobayashi S and Tokimitsu I, 2009. Effects of single oral administration of diacylglycerol oil on dietary fat oxidation. Yakuri To Chiryo [Japanese Pharmacology and Therapeutics], 37, 423–431. [Google Scholar]
  22. Schulz KF and Grimes DA, 2005. Multiplicity in randomised trials II: subgroup and interim analyses. Lancet, 365, 1657–1661. [DOI] [PubMed] [Google Scholar]
  23. Shoji K, Takase H, Tomonobu K, Hibi M, Kudo N, Katsuragi Y, Meguro S and Tokimitsu I, 2008. Effects of diacylglycerol oil on body weight and fat in obese people. Progress in Medicine, 28, 203–210. [Google Scholar]
  24. Taguchi H, Omachi T, Nagao T, Matsuo N, Tokimitsu I and Itakura H, 2002. Dietary diacylglycerol suppresses high fat diet‐induced hepatic fat accumulation and microsomal triacylglycerol transfer protein activity in rats. The Journal of Nutritional Biochemistry, 13, 678–683. [DOI] [PubMed] [Google Scholar]
  25. Takeshita M, Saito S, Moriwaki J, Takase H, Yamada N, Shiiba D, Kudo N, Nakajima Y and Tokimitsu I, 2007. Effects of dietary diacylglycerol oil containing phytosterols on mayonnaise on abdominal fat and blood cholesterol levels in Japanese men. Japanese Pharmacology and Therapeutics, 35, 973–987. [Google Scholar]
  26. Tomonobu K, Hase T, Shiiba D, Kudo N, Nakajima Y, Tokimitsu I and Nakamura H, 2004. Effect of diacylglycerol oil containing phytosterol ester in mayonnaise on anthropometric parameters, serum cholesterol levels and its safety. Progress in Medicine, 24, 2342–2358. [Google Scholar]
  27. Watanabe H, Onizawa K, Taguchi H, Kobori M, Chiba H, Naito S, Matsuo N, Yasukawa T, Hattori M and Shimasaki H, 1997. Nutritional characterization of diacylglycerol in rats. Journal of Japan Oil Chemists' Society, 46, 301–307. [Google Scholar]
  28. Yamamoto K, Tomonobu K, Asakawa H, Tokunaga K, Hase T, Tokimitsu I and Yagi N, 2006. Diet therapy with diacylglycerol oil delays the progression of renal failure in type 2 diabetic patients with nephropathy. Diabetes Care, 29, 417–419. [DOI] [PubMed] [Google Scholar]
  29. Yuan Q, Ramprasath VR, Harding SV, Rideout TC, Chan YM and Jones PJ, 2010. Diacylglycerol oil reduces body fat but does not alter energy or lipid metabolism in overweight, hypertriglyceridemic women. Journal of Nutrition, 140, 1122–1126. [DOI] [PubMed] [Google Scholar]

Articles from EFSA Journal are provided here courtesy of Wiley

RESOURCES